Thomas Jefferson University

Zeynep Bas

TitleVolunteer Faculty
InstitutionThomas Jefferson University
DepartmentOphthalmology - Thomas Jefferson University
Address1025 Walnut Street
Philadelphia PA 19107
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Dockery PW, DeSimone JD, Liu CK, Achuck K, Hamburger J, Bas Z, Shields CL. Effectiveness of treatment for iris melanoma: surgical versus radiotherapeutic approaches. Can J Ophthalmol. 2024 Oct; 59(5):329-334. PMID: 38040029.
      Citations:    
    2. Bas Z, Sajjadi Z, Shields CL. SARCOID GRANULOMA OF THE CHOROID AND CILIARY BODY IN 50 CASES. Retina. 2023 11 01; 43(11):1842-1851. PMID: 37657072.
      Citations:    
    3. Bas Z, Grant-Kels JM, Shields CL. The Cancer Genome Atlas for uveal melanoma is predictive of patient outcomes. Clin Dermatol. 2024 Jan-Feb; 42(1):56-61. PMID: 37890680.
      Citations:    
    4. Shields CL, Samuelson AG, Oh GJ, DeSimone JD, Sajjadi ZL, Bas Z, Kalafatis NE, Lally SE, Shields JA, Dockery PW. Conditional Metastasis of Uveal Melanoma in 8091 Patients over Half-Century (51 Years) by Age Group: Assessing the Entire Population and the Extremes of Age. Invest Ophthalmol Vis Sci. 2023 07 03; 64(10):7. PMID: 37418273.
      Citations:    
    5. Bas Z, Dockery PW, Lally SE, Shields JA, Shields CL. Conjunctival Melanoma in 430 Cases: Comparative Analysis of the Impact of Orbital Invasion on Tumor Recurrence, Metastasis, and Death. Ophthalmic Plast Reconstr Surg. 2023 Jan-Feb 01; 39(1):49-57. PMID: 36598390.
      Citations:    
    6. Shelukar S, Fernandez C, Bas Z, Komarnicky L, Lally SE, Shields CL, Binder A, Porcu P, Alpdogan O, Martinez-Outschoorn U, Shi W. High local control and low ocular toxicity using ultra-low-dose "boom-boom" radiotherapy for indolent orbital lymphoma. Chin Clin Oncol. 2022 Dec; 11(6):44. PMID: 36632978.
      Citations:    
    7. Bas Z, Sharpe J, Yaghy A, Zhang Q, Shields CL, Hyman L. Prevalence of and Associated Factors for Eyelid Cancer in the American Academy of Ophthalmology Intelligent Research in Sight Registry. Ophthalmol Sci. 2023 Mar; 3(1):100227. PMID: 36439695.
      Citations:    
    8. Gelmi MC, Bas Z, Malkani K, Ganguly A, Shields CL, Jager MJ. Reply. Ophthalmology. 2022 Jul; 129(7):e79-e80. PMID: 35431092.
      Citations:    
    9. Shields CL, Bas Z, Laiton A, Silva AMV, Sheikh A, Lally SE, Shields JA. Retinoblastoma: emerging concepts in genetics, global disease burden, chemotherapy outcomes, and psychological impact. Eye (Lond). 2023 04; 37(5):815-822. PMID: 35217824.
      Citations:    
    10. Sajjadi Z, Bas Z, Shields CL. Hyperreflective band on anterior segment optical coherence tomography. Indian J Ophthalmol. 2022 Feb; 70(2):361. PMID: 35086197.
      Citations:    
    11. Williamson Iii JE, Bas Z, Shields CL. Angiography of Florid Tunica Vasculosa Lentis in Persistent Fetal Vasculature. J Pediatr Ophthalmol Strabismus. 2022 May-Jun; 59(3):204. PMID: 34928764.
      Citations:    
    12. Shields CL, Dockery PW, Mayro EL, Bas Z, Yaghy A, Lally SE, Orloff M, Sato T, Shields JA. Conditional survival of uveal melanoma using The Cancer Genome Atlas (TCGA) classification (Simplified Version) in 1001 cases. Saudi J Ophthalmol. 2022 Jul-Sep; 36(3):308-314. PMID: 36276251.
      Citations:    
    13. Gelmi MC, Bas Z, Malkani K, Ganguly A, Shields CL, Jager MJ. Adding the Cancer Genome Atlas Chromosome Classes to American Joint Committee on Cancer System Offers More Precise Prognostication in Uveal Melanoma. Ophthalmology. 2022 04; 129(4):431-437. PMID: 34793831.
      Citations:    
    14. Wierenga APA, Brouwer NJ, Gelmi MC, Verdijk RM, Stern MH, Bas Z, Malkani K, van Duinen SG, Ganguly A, Kroes WGM, Marinkovic M, Luyten GPM, Shields CL, Jager MJ. Chromosome 3 and 8q Aberrations in Uveal Melanoma Show Greater Impact on Survival in Patients with Light Iris versus Dark Iris Color. Ophthalmology. 2022 04; 129(4):421-430. PMID: 34780841.
      Citations:    
    15. Shields CL, Mayro EL, Bas Z, Dockery PW, Yaghy A, Lally SE, Ganguly A, Shields JA. Ten-year outcomes of uveal melanoma based on The Cancer Genome Atlas (TCGA) classification in 1001 cases. Indian J Ophthalmol. 2021 07; 69(7):1839-1845. PMID: 34146040.
      Citations:    
    16. Bas Z, Yaghy A, Shields CL. Iris melanoma with neovascularization in sector melanocytosis controlled with 125I plaque radiotherapy and bevacizumab. J Fr Ophtalmol. 2021 May; 44(5):738-739. PMID: 33610395.
      Citations:    
    17. Bas Z, Dalvin LA, Tadepalli S, Rao R, Shah A, Leahey AM, Shields CL. Outcomes of Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma Based on Patient Age in 964 Eyes of 554 Patients. Asia Pac J Ophthalmol (Phila). 2021 Jan 19; 10(4):373-380. PMID: 33481399.
      Citations:    
    18. Tekeli O, Elgin U, Takmaz T, Eksioglu ?, Bas Z, Yarang?meli A, Karakurt A, Evren Kemer ?, Mumcuoglu T, Aktas Z, Akman A, Bayer A. Characteristics of uveitic glaucoma in Turkish patients. Eur J Ophthalmol. 2021 Jul; 31(4):1836-1843. PMID: 32799547.
      Citations:    
    19. Dalvin LA, Bas Z, Tadepalli S, Rao R, Vaidya S, Pacheco R, Shields CL. Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients. J Pediatr Ophthalmol Strabismus. 2020 Jul 01; 57(4):224-234. PMID: 32687206.
      Citations:    
    20. Shields CL, Bas Z, Tadepalli S, Dalvin LA, Rao R, Schwendeman R, Lally SE, Shields JA, Shah A, Leahey A. Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre. Br J Ophthalmol. 2020 11; 104(11):1548-1555. PMID: 32051141.
      Citations:    
    21. Bas Z, U?akhan G?nd?z ?. Sutureless Amniotic Membrane Transplantation in a Pediatric Patient with Acute Toxic Epidermal Necrolysis Turk J Ophthalmol. 2019 12 31; 49(6):356-360. PMID: 31893592.
      Citations:    
    22. Bas Z, Bayraktutar BN, U?akhan ??. Severe Dry Eye in CD25 Deficiency Syndrome. Eye Contact Lens. 2018 Jan; 44(1):e1-e3. PMID: 29252577.
      Citations:    
    23. Demirel S, Yanik ?, Batioglu F, ?zmert E, Bas Z. Aqueous Flare as an Indicator of Response to Dexamethasone Treatment in Retinal Vein Occlusions: A Pilot Study. Curr Eye Res. 2016 05; 41(5):700-7. PMID: 26237082.
      Citations:    
    Bas's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (103)
    Explore
    _
    Co-Authors (8)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _